Search Results - "Bhattarai, Shristi"

Quadruple-negative breast cancer: novel implications for a new disease by Bhattarai, Shristi, Saini, Geetanjali, Gogineni, Keerthi, Aneja, Ritu

“…Based on the androgen receptor (AR) expression, triple-negative breast cancer (TNBC) can be subdivided into AR-positive TNBC and AR-negative TNBC, also known…”
Get full text

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer by Garlapati, Chakravarthy, Joshi, Shriya, Bhattarai, Shristi, Krishnamurthy, Jayashree, Turaga, Ravi Chakra, Nguyen, Thi, Li, Xiaoxian, Aneja, Ritu

“…Protein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. The mitotic…”
Get full text

A novel prognostic two-gene signature for triple negative breast cancer by Alsaleem, Mansour A., Ball, Graham, Toss, Michael S., Raafat, Sara, Aleskandarany, Mohammed, Joseph, Chitra, Ogden, Angela, Bhattarai, Shristi, Rida, Padmashree C.G., Khani, Francesca, Davis, Melissa, Elemento, Olivier, Aneja, Ritu, Ellis, Ian O., Green, Andrew, Mongan, Nigel P., Rakha, Emad

“…The absence of a robust risk stratification tool for triple negative breast cancer (TNBC) underlies imprecise and nonselective treatment of these patients with…”
Get full text

Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer by Joshi, Shriya, Garlapati, Chakravarthy, Bhattarai, Shristi, Su, Yixin, Rios-Colon, Leslimar, Deep, Gagan, Torres, Mylin A, Aneja, Ritu

“…Neoadjuvant chemotherapy (NAC) is commonly used in breast cancer (BC) patients to increase eligibility for breast-conserving surgery. Only 30% of patients with…”
Get full text

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer by Fisher, Timothy B, Saini, Geetanjali, Rekha, T S, Krishnamurthy, Jayashree, Bhattarai, Shristi, Callagy, Grace, Webber, Mark, Janssen, Emiel A M, Kong, Jun, Aneja, Ritu

“…Pathological complete response (pCR) is associated with favorable prognosis in patients with triple-negative breast cancer (TNBC). However, only 30-40% of TNBC…”
Get full text

Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers by Ogden, Angela, Bhattarai, Shristi, Sahoo, Bikram, Mongan, Nigel P., Alsaleem, Mansour, Green, Andrew R., Aleskandarany, Mohammed, Ellis, Ian O., Pattni, Sonal, Li, Xiaoxian (Bill), Moreno, Carlos S., Krishnamurti, Uma, Janssen, Emiel A., Jonsdottir, Kristin, Rakha, Emad, Rida, Padmashree, Aneja, Ritu

“…Epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 3 (HER3) have been investigated as triple-negative breast cancer (TNBC)…”
Get full text

QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation by Bhattarai, Shristi, Sugita, Bruna M, Bortoletto, Stefanne M, Fonseca, Aline S, Cavalli, Luciane R, Aneja, Ritu

“…Triple-negative breast cancer (TNBC) can be further classified into androgen receptor (AR)-positive TNBC and AR-negative TNBC or quadruple-negative breast…”
Get full text

Quadruple-Negative Breast Cancer: An Uneven Playing Field by Saini, Geetanjali, Bhattarai, Shristi, Gogineni, Keerthi, Aneja, Ritu

Get full text

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis by Klimov, Sergey, Xue, Yue, Gertych, Arkadiusz, Graham, Rondell P, Jiang, Yi, Bhattarai, Shristi, Pandol, Stephen J, Rakha, Emad A, Reid, Michelle D, Aneja, Ritu

“…The prognosis of patients with pancreatic neuroendocrine tumors (PanNET), the second most common type of pancreatic cancer, varies significantly, and up to 15%…”
Get full text

Extremely Elevated Prostate-Specific Antigen in Acute Prostatitis: A Case Report by Nepal, Anamika, Sharma, Prabhat, Bhattarai, Shristi, Mahajan, Zubin, Sharma, Akhya, Sapkota, Ashok, Sharma, Aviskar

“…Elevated prostate-specific antigen (PSA) levels are mostly suggestive of prostate cancer, but they are elevated in non-cancerous prostatic conditions as well…”
Get full text

Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors by Nwagu, Gift C, Bhattarai, Shristi, Swahn, Monica, Ahmed, Saad, Aneja, Ritu

Get full text

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients by Xu, Qi, Kaur, Jaspreet, Wylie, Dennis, Mittal, Karuna, Li, Hongxiao, Kolachina, Rishab, Aleskandarany, Mohammed, Toss, Michael S., Green, Andrew R., Yang, Jianchen, Yankeelov, Thomas E., Bhattarai, Shristi, Janssen, Emiel A. M., Kong, Jun, Rakha, Emad A., Kowalski, Jeanne, Aneja, Ritu

“…Extensive intratumoral heterogeneity (ITH) is believed to contribute to therapeutic failure and tumor recurrence, as treatment-resistant cell clones can…”
Get full text

Deep learning based registration of serial whole-slide histopathology images in different stains by Roy, Mousumi, Wang, Fusheng, Teodoro, George, Bhattarai, Shristi, Bhargava, Mahak, Rekha, T. Subbanna, Aneja, Ritu, Kong, Jun

“…For routine pathology diagnosis and imaging-based biomedical research, Whole-slide image (WSI) analyses have been largely limited to a 2D tissue image space…”
Get full text

Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in Georgia by Awan, Sofia, Saini, Geetanjali, Gogineni, Keerthi, Luningham, Justin M., Collin, Lindsay J., Bhattarai, Shristi, Aneja, Ritu, Williams, Courtney P.

“…Background Little is known regarding the association between insurance status and treatment delays in women with breast cancer and whether this association…”
Get full text

Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment by Saxena, Roopali, Yang, Chunhua, Rao, Mukkavilli, Turaga, Ravi Chakra, Garlapati, Chakravarthy, Gundala, Sushma Reddy, Myers, Kimberly, Ghareeb, Ahmed, Bhattarai, Shristi, Kamalinia, Golnaz, Bristi, Sangina, Su, Dan, Gadda, Giovanni, Rida, Padmashree C G, Cantuaria, Guilherme H, Aneja, Ritu

“…Most currently available chemotherapeutic agents target rampant cell division in cancer cells, thereby affecting rapidly dividing normal cells resulting in…”
Get full text

Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning by Bhattarai, Shristi, Saini, Geetanjali, Li, Hongxiao, Seth, Gaurav, Fisher, Timothy B, Janssen, Emiel A M, Kiraz, Umay, Kong, Jun, Aneja, Ritu

“…Neoadjuvant chemotherapy (NAC) is the standard treatment for early-stage triple negative breast cancer (TNBC). The primary endpoint of NAC is a pathological…”
Get full text

Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer by Bhattarai, Shristi, Rupji, Manali, Chao, Hsueh-ping, Xu, Qi, Saini, Geetanjali, Rida, Padmashree, Aleskandarany, Mohammed A., Green, Andrew R., Ellis, Ian O., Janssen, Emiel A., Jonsdottir, Kristin, Rakha, Emad, Kowalski, Jeanne, Aneja, Ritu

“…Background Ki67 index (KI) and mitotic index (MI) are proliferation markers with established prognostic value in breast carcinomas. While KI is evaluated…”
Get full text

Abstract C101: A prognostic risk model for African American women with breast cancer: Implications for meaningful accrual in clinical trials by Bhattarai, Shristi, Klimov, Sergey, Aneja, Ritu

“…Background: Racial disparities in breast cancer outcomes appear to be widening in the US despite multiple advancements in breast cancer (BC) management…”
Get full text

Abstract P3-09-13: Androgen receptor loss is associated with genomic instability characterized by copy number alterations and mirna deregulation in triple-negative breast cancer by Bhattarai, Shristi, Sugita, Bruna M., Cavalli, Luciane, Aneja, Ritu

“…Background: Triple-negative breast cancer (TNBC) comprises 10%-20% of invasive breast carcinoma cases. Patients with TNBC exhibit poorer 5-year survival and…”
Get full text

Abstract P2-12-24: Exosomal metabolic signatures are associated with differential response to neoadjuvant chemotherapy in patients with breast cancer by Joshi, Shriya, Garalapati, Chakravarthy, Bhattarai, Shristi, Chandrashekar, Darshan Shimoga, Varambally, Sooryanarayana, Deep, Gagan, Aneja, Ritu

“…Background: Neoadjuvant chemotherapy (NAC) is becoming the standard of care for aggressive breast cancer (BC). In patients with BC, NAC can increase…”
Get full text